/PRNewswire/ The "Out-of-Pocket Healthcare Expenditures in the United States, 5th Edition" report has been added to ResearchAndMarkets.com s offering. This.
Frost and Sullivan
According to a recent report by international growth partnership company Frost and Sullivan, Western Europe’s medical device market is on track to recover from the COVID-19 pandemic by 2023.
The report, titled ‘Impact of COVID-19 on Elective Procedures in Western Europe, 2020–2023’, projects that the market for selective medical devices for elective procedures will reach $16.8 billion (€13.76B) by 2023. according to an aspirational compound annual growth rate of 29.2%.
WHY IT MATTERS
Because of COVID-19, there was a 45.5% decline in the selective medical devices market for elective procedures from the pre-COVID projections for 2020. However, the restrictions and challenges raised by the pandemic have forced medical device manufacturers to think in new ways, creating growth opportunities in the sector.
Elective Procedures in Western Europe 2020-2023: COVID-19 Impact in Western European Nations globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Research and Markets: Impact of COVID-19 on Elective Procedures in Western Europe 2020-2023 - ResearchAndMarkets.com
ResearchAndMarkets.com s offering.
The deferral of elective procedures due to pandemic-related measures has adversely affected the cardiovascular medical devices market. While some cardiovascular procedures are considered urgent, others have been rescheduled and deferred.
Nearly 80% of all the orthopedic procedures performed in Europe are estimated to have been delayed, postponed, or canceled due to COVID-19, as they are considered to be elective and non-essential procedures. Traumas, amputations, and oncological procedures are considered to be the most essential. Dislocations and fractures, including hip, pelvis, and forearms, are only being considered for treatment in urgent cases. COVID-19 patient volumes are putting a strain on intensive care resources. Providers are witnessing a decrease in ambulatory care and elective surgeries, even as the infection is spre
Share this article
Share this article
ResearchAndMarkets.com s offering.
The study offers an overview of the impact of COVID-19 on select medical devices.
The deferral of elective procedures due to COVID-19-related measures has affected the cardiovascular medical device market. While some cardiovascular procedures are considered urgent, others have been rescheduled and deferred. Nearly 83.5% of all orthopedic procedures performed in the United States have been delayed, postponed, or canceled since the COVID-19 outbreak, as they are considered to be elective and non-essential. Traumas, amputations, and oncological procedures are the top essential procedures. Dislocations and fractures, including hip, pelvis, and forearms, are considered for treatment only in urgent cases.